Announcements Trials
Browse Landscape

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Tumor-Agnostic 2Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Neoplasms, Second Primary 1Neoplasms 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Registries × 1 year × Clear all
NCT03413982 2026-03-10

GUB-BCR-001

University of Kansas Medical Center

Recruiting
1,000 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT04511806 2025-10-29

CCPS

Emory University

Recruiting
1,050 enrolled
Tumor-Agnostic

Neoplasms

NCT04376229 2025-07-01

Proton Radiation Therapy Registry

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Recruiting
5,000 enrolled
Tumor-Agnostic

Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡